Skip to content
Monday, November 16, 2026
Explore cutting-edge trends in fashion, technology, and lif…

Patients Coming Off Weight-Loss Jabs Regain Pounds Far More Rapidly Than Dieters

Illustration of medical injection and weighing machine
Obesity treatment involves ongoing approaches.

Fresh analysis reveals that individuals who stop using popular weight-loss injections like Mounjaro or Wegovy can put back on shed pounds far faster than those who end traditional diet and exercise programs.

Findings released in a prominent medical journal points out that while overweight people often shed about a fifth of their total mass while on the medication, the weight is regained at an estimated rate of 0.8 kg per month upon discontinuation.

"Individuals purchasing these treatments should be aware of the potential of rapid weight regain when the therapy ends," warns lead investigator Dr. Susan Jebb.

That rate of regain means a reversion to original mass in about a year and a half.

Comparing Approaches

The study, which reviewed 37 of studies involving over 9,000 of patients, contrasted the results of these new drugs with conventional dieting.

Researchers point out that people who shed pounds through diet and exercise typically have a less rapid creep back—around 100 grams monthly—post-intervention.

Understanding the Quick Rebound

Experts suggest the way of the drugs explains the accelerated regain.

GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which helps regulate hunger.

"Artificially providing the hormone concentrations several times higher than the body's typical production could lead to the body to generate a reduced amount of its endogenous hormone, and could reduce responsiveness to its effects," said Dr. Adam Collins, a nutrition expert.

"Stopping of this GLP-1 'fix' means hunger is unsuppressed, making overeating far more likely."

A Lifelong Issue?

The NHS suggest the jabs for individuals with weight-linked medical conditions, accompanied by prescribed lifestyle changes.

Professionals contend that, given the high risk of weight regain, the treatment is often long-term.

This opinion is echoed by drug manufacturers, who say that the findings "underscore the persistent nature of excess weight," akin to managing diseases like high blood pressure.

Patient Experiences

Users who have stopped the jabs report a sudden return of hunger.

"It was like a trigger flipping and you become starving," recalled one woman.

This challenge is compounded if users have not developed lasting lifestyle or habit modifications during treatment.

Growing Adoption

Figures suggest that millions of people in the UK have used these injections in the last 12 months, with desire remaining high.

  • Adoption is higher among females compared to men.
  • The 40s and 50s age group shows the greatest level of interest.
  • Many access the drugs through private healthcare rather than the NHS.

In conclusion, experts emphasize that while the jabs are effective tools for shedding pounds, they are not a standalone solution and lasting health benefits relies on combined behavioural changes.

The writer

Karen Harris

Elara Vance is a trend analyst and digital content creator with a passion for uncovering emerging styles and innovations across global markets.

Trend Central Hub

Type to search articles.